DK2630159T3 - Stable and soluble antibodies - Google Patents

Stable and soluble antibodies Download PDF

Info

Publication number
DK2630159T3
DK2630159T3 DK11776322.7T DK11776322T DK2630159T3 DK 2630159 T3 DK2630159 T3 DK 2630159T3 DK 11776322 T DK11776322 T DK 11776322T DK 2630159 T3 DK2630159 T3 DK 2630159T3
Authority
DK
Denmark
Prior art keywords
xaa xaa
antibody
ser
gly
amino acid
Prior art date
Application number
DK11776322.7T
Other languages
Danish (da)
English (en)
Inventor
Leonardo Borras
David Urech
Original Assignee
Esbatech A Novartis Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esbatech A Novartis Co Llc filed Critical Esbatech A Novartis Co Llc
Priority claimed from PCT/CH2011/000256 external-priority patent/WO2012051734A1/en
Application granted granted Critical
Publication of DK2630159T3 publication Critical patent/DK2630159T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK11776322.7T 2010-10-22 2011-10-24 Stable and soluble antibodies DK2630159T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40579810P 2010-10-22 2010-10-22
US201161405798P 2011-05-11 2011-05-11
PCT/CH2011/000256 WO2012051734A1 (en) 2010-10-22 2011-10-24 Stable and soluble antibodies

Publications (1)

Publication Number Publication Date
DK2630159T3 true DK2630159T3 (en) 2018-02-26

Family

ID=45637301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11776322.7T DK2630159T3 (en) 2010-10-22 2011-10-24 Stable and soluble antibodies

Country Status (6)

Country Link
DK (1) DK2630159T3 (es)
ES (2) ES2660613T3 (es)
HR (1) HRP20180302T1 (es)
HU (1) HUE036125T2 (es)
LT (1) LT2630159T (es)
PT (1) PT2630159T (es)

Also Published As

Publication number Publication date
HRP20180302T1 (hr) 2018-05-04
LT2630159T (lt) 2018-03-12
ES2848556T3 (es) 2021-08-10
ES2660613T3 (es) 2018-03-23
HUE036125T2 (hu) 2018-06-28
PT2630159T (pt) 2018-02-28

Similar Documents

Publication Publication Date Title
US10570198B2 (en) Stable and soluble antibodies
CA2727992C (en) Stable and soluble antibodies inhibiting tnf.alpha.
AU2016277637B2 (en) Stable and soluble antibodies
DK2630159T3 (en) Stable and soluble antibodies
AU2013203189B2 (en) Stable and soluble antibodies